1887

Journal of General Virology header logo

Volume 83, Issue 6

Human adenovirus serotypes 4p and 11p are efficiently expressed in cell lines of neural tumour origin Free

Abstract

Most currently used adenovirus vectors are based upon adenovirus serotypes 2 and 5 (Ad2 and Ad5), which have limited efficiencies for gene transfer to human neural cells. Both serotypes bind to the known adenovirus receptor, CAR (coxsackievirus and adenovirus receptor), and have restricted cell tropism. The purpose of this study was to find vector candidates that are superior to Ad5 in infecting human neural tumours. Using flow cytometry, the vector candidates Ad4p, Ad11p and Ad17p were compared to the commonly used adenovirus vector Ad5v for their binding capacity to neural cell lines derived from glioblastoma, medulloblastoma and neuroblastoma cell lines. The production of viral structural proteins and the CAR-binding properties of the different serotypes were also assessed in these cells. Computer-based models of the fibre knobs of Ad4p and Ad17 were created based upon the crystallized fibre knob structure of adenoviruses and analysed for putative receptor-interacting regions that differed from the fibre knob of Ad5. The non CAR-binding vector candidate Ad11p showed clearly the best binding capacity to all of the neural cell lines, binding more than 90% of cells of all of the neural cell lines tested, in contrast to 20% or less for the commonly used vector Ad5v. Ad4p and Ad11p were also internalized and produced viral proteins more successfully than Ad5. Ad4p showed a low binding ability but a very efficient capacity for infection in cell culture. Ad17p virions neither bound or efficiently infected any of the neural cell lines studied.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-6-1299
2002-06-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/6/0831299a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-6-1299&mimeType=html&fmt=ahah

References

  1. Adrian T., Wadell G., Hierholzer J. C., Wigand R. 1986; DNA restriction analysis of adenovirus prototypes 1 to 41. Archives of Virology 91:277–290
     [Google Scholar]
  2. Alton E., Kitson C. 2000; Gene therapy for cystic fibrosis. Expert Opinion on Investigational Drugs 9:1523–1535
     [Google Scholar]
  3. Arnberg N., Edlund K., Kidd A. H., Wadell G. 2000a; Adenovirus type 37 uses sialic acid as a cellular receptor. Journal of Virology 74:42–48
     [Google Scholar]
  4. Arnberg N., Kidd A. H., Edlund K., Olfat F., Wadell G. 2000b; Initial interactions of subgenus D adenoviruses with A549 cellular receptors: sialic acid versus αv integrins. Journal of Virology 74:7691–7693
     [Google Scholar]
  5. Asaoka K., Tada M., Sawamura Y., Ikeda J., Abe H. 2000; Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor. Journal of Neurosurgery 92:1002–1008
     [Google Scholar]
  6. Bergelson J. M., St John N., Kawaguchi S., Chan M., Stubdal H., Modlin J., Finberg R. W. 1993; Infection by echoviruses 1 and 8 depends on the α2 subunit of human VLA-2. Journal of Virology 67:6847–6852
     [Google Scholar]
  7. Bergelson J. M., Cunningham J. A., Droguett G., Kurt-Jones E. A., Krithivas A., Hong J. S., Horwitz M. S., Crowell R. L., Finberg R. W. 1997; Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320–1323
     [Google Scholar]
  8. Bewley M. C., Springer K., Zhang Y. B., Freimuth P., Flanagan J. M. 1999; Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science 286:1579–1583
     [Google Scholar]
  9. Byrnes A. P., Rusby J. E., Wood M. J., Charlton H. M. 1995; Adenovirus gene transfer causes inflammation in the brain. Neuroscience 66:1015–1024
     [Google Scholar]
  10. Byrnes A. P., Wood M. J., Charlton H. M. 1996; Role of T cells in inflammation caused by adenovirus vectors in the brain. Gene Therapy 3:644–651
     [Google Scholar]
  11. Chillon M., Bosch A., Zabner J., Law L., Armentano D., Welsh M. J., Davidson B. L. 1999; Group D adenoviruses infect primary central nervous system cells more efficiently than those from group C. Journal of Virology 73:2537–2540
     [Google Scholar]
  12. Choi-Lundberg D., Rosenthal A. 1999; Autotransplantation for Parkinson’s disease goes a step further. Neuron 22:635–636
     [Google Scholar]
  13. Chroboczek J., Ruigrok R. W., Cusack S. 1995; Adenovirus fiber. Current Topics in Microbiology and Immunology 199:163–200
     [Google Scholar]
  14. Ebihara S., Guibinga G. H., Gilbert R., Nalbantoglu J., Massie B., Karpati G., Petrof B. J. 2000; Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice. Physiological Genomics 3:133–144
     [Google Scholar]
  15. Ehrengruber M. U., Hennou S., Bueler H., Naim H. Y., Deglon N., Lundstrom K. 2001; Gene transfer into neurons from hippocampal slices: comparison of recombinant Semliki Forest virus, adenovirus, adeno-associated virus, lentivirus, and measles Virus. Molecular and Cellular Neurosciences 17:855–871
     [Google Scholar]
  16. Fasbender A., Zabner J., Chillon M., Moninger T. O., Puga A. P., Davidson B. L., Welsh M. J. 1997; Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo . Journal of Biological Chemistry 272:6479–6489
     [Google Scholar]
  17. Fasbender A., Lee J. H., Walters R. W., Moninger T. O., Zabner J., Welsh M. J. 1998; Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo . Journal of Clinical Investigation 102:184–193
     [Google Scholar]
  18. Fenner F., McAuslan B. R., Mims C. A., Sambrook J., White D. O. 1974; The biology of animal viruses. In The Biology of Human Viruses pp 191–198 Edited by Fenner F. New York: Academic Press;
     [Google Scholar]
  19. Fisher K. J., Choi H., Burda J., Chen S. J., Wilson J. M. 1996; Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217:11–22
     [Google Scholar]
  20. Fox J. P., Hall C. E. (editors) 1980 Viruses in Families p–318 Littleton, MA: PSG Publishing;
     [Google Scholar]
  21. Graham F. L. 1984; Covalently closed circles of human adenovirus DNA are infectious. EMBO Journal 3:2917–2922
     [Google Scholar]
  22. Graham F. L., Rudy J., Brinkley P. 1989; Infectious circular DNA of human adenovirus type 5: regeneration of viral DNA termini from molecules lacking terminal sequences. EMBO Journal 8:2077–2085
     [Google Scholar]
  23. Gruber W. C., Russell D. J., Tibbetts C. 1993; Fiber gene and genomic origin of human adenovirus type 4. Virology 196:603–611
     [Google Scholar]
  24. Guex N., Peitsch M. C. 1997; SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18:2714–2723
     [Google Scholar]
  25. Guex N., Diemand A., Peitsch M. C. 1999; Protein modelling for all. Trends in Biochemical Sciences 24:364–367
     [Google Scholar]
  26. Habib N. A., Hodgson H. J., Lemoine N., Pignatelli M. 1999; A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours. Human Gene Therapy 10:2019–2034
     [Google Scholar]
  27. Hermens W. T., Verhaagen J. 1998; Viral vectors, tools for gene transfer in the nervous system. Progress in Neurobiology 55:399–432
     [Google Scholar]
  28. Honda T., Saitoh H., Masuko M., Katagiri-Abe T., Tominaga K., Kozakai I., Kobayashi K., Kumanishi T., Watanabe Y. G., Odani S., Kuwano R. 2000; The coxsackievirus–adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain. Brain research: Molecular Brain Research 77:19–28
     [Google Scholar]
  29. Hong S. S., Karayan L., Tournier J., Curiel D. T., Boulanger P. A. 1997; Adenovirus type 5 fiber knob binds to MHC class I α2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO Journal 16:2294–2306
     [Google Scholar]
  30. Kajiwara K., Byrnes A. P., Ohmoto Y., Charlton H. M., Wood M. J., Wood K. J. 2000; Humoral immune responses to adenovirus vectors in the brain. Journal of Neuroimmunology 103:8–15
     [Google Scholar]
  31. Kaplan J. M., Pennington S. E., St George J. A., Woodworth L. A., Fasbender A., Marshall J., Cheng S. H., Wadsworth S. C., Gregory R. J., Smith A. E. 1998; Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential. Human Gene Therapy 9:1469–1479
     [Google Scholar]
  32. Kaplitt M. G., Makimura H. 1997; Defective viral vectors as agents for gene transfer in the nervous system. Journal of Neuroscience Methods 71:125–132
     [Google Scholar]
  33. Kochanek S., Clemens P. R., Mitani K., Chen H. H., Chan S., Caskey C. T. 1996; A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proceedings of the National Academy of Sciences, USA 93:5731–5736
     [Google Scholar]
  34. Kremer E. J., Boutin S., Chillon M., Danos O. 2000; Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. Journal of Virology 74:505–512
     [Google Scholar]
  35. Lang F. F., Yung W. K., Sawaya R., Tofilon P. J. 1999; Adenovirus-mediated p53 gene therapy for human gliomas. Neurosurgery 45:1093–1104
     [Google Scholar]
  36. Ludwig S. L., Brundage J. F., Kelley P. W., Nang R., Towle C., Schnurr D. P., Crawford-Miksza L., Gaydos J. C. 1998; Prevalence of antibodies to adenovirus serotypes 4 and 7 among unimmunized US Army trainees: results of a retrospective nationwide seroprevalence survey. Journal of Infectious Diseases 178:1776–1778
     [Google Scholar]
  37. Marini F. C.III., Yu Q., Wickham T., Kovesdi I., Andreeff M. 2000; Adenovirus as a gene therapy vector for hematopoietic cells. Cancer Gene Therapy 7:816–825
     [Google Scholar]
  38. Mei Y. F., Lindman K., Wadell G. 1998; Two closely related adenovirus genome types with kidney or respiratory tract tropism differ in their binding to epithelial cells of various origins. Virology 240:254–266
     [Google Scholar]
  39. Miller C. R., Buchsbaum D. J., Reynolds P. N., Douglas J. T., Gillespie G. Y., Mayo M. S., Raben D., Curiel D. T. 1998; Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Research 58:5738–5748
     [Google Scholar]
  40. Miyazawa N., Leopold P. L., Hackett N. R., Ferris B., Worgall S., Falck-Pedersen E., Crystal R. G. 1999; Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors. Journal of Virology 73:6056–6065
     [Google Scholar]
  41. Miyazawa N., Crystal R. G., Leopold P. L. 2001; Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein. Journal of Virology 75:1387–1400
     [Google Scholar]
  42. Mori T., Arakawa H., Tokino T., Mineura K., Nakamura Y. 1999; Significant increase of adenovirus infectivity in glioma cell lines by extracellular domain of hCAR. Oncology Research 11:513–521
     [Google Scholar]
  43. Musgrave D. S., Bosch P., Lee J. Y., Pelinkovic D., Ghivizzani S. C., Whalen J., Niyibizi C., Huard J. 2000; Ex vivo gene therapy to produce bone using different cell types. Clinical Orthopaedics Research 378:290–305
     [Google Scholar]
  44. Peitsch M. C. 1995; Protein modeling by e-mail. Biotechnology 13:658–660
     [Google Scholar]
  45. Pickles R. J., Fahrner J. A., Petrella J. M., Boucher R. C., Bergelson J. M. 2000; Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer. Journal of Virology 74:6050–6057
     [Google Scholar]
  46. Piedra P. A., Poveda G. A., Ramsey B., McCoy K., Hiatt P. W. 1998; Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors. Pediatrics 101:1013–1019
     [Google Scholar]
  47. Rebel V. I., Hartnett S., Denham J., Chan M., Finberg R., Sieff C. A. 2000; Maturation and lineage-specific expression of the coxsackie and adenovirus receptor in hematopoietic cells. Stem Cells 18:176–182
     [Google Scholar]
  48. Reynolds P. N., Zinn K. R., Gavrilyuk V. D., Balyasnikova I. V., Rogers B. E., Buchsbaum D. J., Wang M. H., Miletich D. J., Grizzle W. E., Douglas J. T., Danilov S. M., Curiel D. T. 2000; A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo . Molecular Therapy 2:562–578
     [Google Scholar]
  49. Roelvink P. W., Lizonova A., Lee J. G., Li Y., Bergelson J. M., Finberg R. W., Brough D. E., Kovesdi I., Wickham T. J. 1998; The coxsackievirus–adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. Journal of Virology 72:7909–7915
     [Google Scholar]
  50. Roelvink P. W., Lee G. M., Einfeld D. A., Kovesdi I., Wickham T. J. 1999; Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing Adenoviridae . Science 286:1568–1571
     [Google Scholar]
  51. Russell W. C. 2000; Update on adenovirus and its vectors. Journal of General Virology 81:2573–2604
     [Google Scholar]
  52. Russell D. W., Hirata R. K. 1998; Human gene targeting by viral vectors. Nature Genetics 18:325–330
     [Google Scholar]
  53. Schiedner G., Morral N., Parks R. J., Wu Y., Koopmans S. C., Langston C., Graham F. L., Beaudet A. L., Kochanek S. 1998; Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nature Genetics 18:180–183
     [Google Scholar]
  54. Segerman A., Mei Y. F., Wadell G. 2000; Adenovirus types 11p and 35p show high binding efficiencies for committed hematopoietic cell lines and are infective to these cell lines. Journal of Virology 74:1457–1467
     [Google Scholar]
  55. Shayakhmetov D. M., Lieber A. 2000; Dependence of adenovirus infectivity on length of the fiber shaft domain. Journal of Virology 74:10274–10286
     [Google Scholar]
  56. Thomas C. E., Schiedner G., Kochanek S., Castro M. G., Lowenstein P. R. 2000; Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic diseases. Proceedings of the National Academy of Sciences, USA 97:7482–7487
     [Google Scholar]
  57. Tomko R. P., Johansson C. B., Totrov M., Abagyan R., Frisen J., Philipson L. 2000; Expression of the adenovirus receptor and its interaction with the fiber knob. Experimental Cell Research 255:47–55
     [Google Scholar]
  58. Toyoda K., Ooboshi H., Chu Y., Fasbender A., Davidson B. L., Welsh M. J., Heistad D. D. 1998; Cationic polymer and lipids enhance adenovirus-mediated gene transfer to rabbit carotid artery. Stroke 29:2181–2188
     [Google Scholar]
  59. Trask T. W., Trask R. P., Aguilar-Cordova E., Shine H. D., Wyde P. R., Goodman J. C., Hamilton W. J., Rojas-Martinez A., Chen S. H., Woo S. L., Grossman R. G. 2000; Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors. Molecular Therapy 1:195–203
     [Google Scholar]
  60. Wadell G. 1999; Adenoviruses ( Adenoviridae ): general features. In Encyclopaedia of Virology pp 1–7 Edited by Webster R. G., Granoff A. London: Academic Press;
     [Google Scholar]
  61. van Raaij M. J., Louis N., Chroboczek J., Cusack S. 1999; Structure of the human adenovirus serotype 2 fiber head domain at 1·5 Å resolution. Virology 262:333–343
     [Google Scholar]
  62. Wickham T. J., Mathias P., Cheresh D. A., Nemerow G. R. 1993; Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment. Cell 73:309–319
     [Google Scholar]
  63. Wood M. J., Charlton H. M., Wood K. J., Kajiwara K., Byrnes A. P. 1996; Immune responses to adenovirus vectors in the nervous system. Trends in Neuroscience 19:497–501
     [Google Scholar]
  64. Xia D., Henry L. J., Gerard R. D., Deisenhofer J. 1994; Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1·7 Å resolution. Structure 2:1259–1270
     [Google Scholar]
  65. Zabner J., Chillon M., Grunst T., Moninger T. O., Davidson B. L., Gregory R., Armentano D. 1999; A chimeric type 2 adenovirus vector with a type 17 fiber enhances gene transfer to human airway epithelia. Journal of Virology 73:8689–8695
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-6-1299
Loading
Human adenovirus serotypes 4p and 11p are efficiently expressed in cell lines of neural tumour origin
J. Gen. Virol. 83, 1299 (2002); https://doi.org/10.1099/0022-1317-83-6-1299
/content/journal/jgv/10.1099/0022-1317-83-6-1299
/content/journal/jgv/10.1099/0022-1317-83-6-1299
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error